Envafolimab for Soft Tissue Sarcoma Granted Orphan Drug Status
An Orphan Drug designation is granted to drugs or biologics intended to treat patients with rare diseases or conditions, affecting less than 200,000 Americans. Because it can sometimes be difficult…